Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin on Postoperative Opioid Consumption in Rhinoplasty
NCT03498261Phase 1Active, not recruiting
- Sponsor
- The Ohio State University
- Start
- Jan 2018
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain comparing Gabapentin with Placebo (2 arms). Primary endpoint: Postoperative Opioid Consumption at 72 hours. Started Jan 2018; status: active, not recruiting.
02
Drugs
gabapentin
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03498261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03498261.